SynthesisOrphanet journal of rare diseases2015

Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis.

Alastair K Denniston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.